Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trigger Point Injections for Postsurgical Pain After Anterior Cervical Surgery
NCT04640896Phase 4Completed
- Sponsor
- George Washington University
- Start
- Nov 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in myofascial pain syndrome (MPS), postoperative pain, sponsored by George Washington University. Started Nov 2020; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
myofascial pain syndrome (MPS)postoperative pain
Beyond the preview
Go deeper on NCT04640896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04640896.